PMS2 and colorectal carcinoma: In patients with PMS2 variants, carcinogenesis may be more akin to the traditional adenoma-carcinoma sequence (25, 48) leading to low CRC incidence which may justify the suggestion from the European Mallorca guidelines for 5-yearly surveillance (35).